Persist AI
Woodland · Founded 2022
About Persist AI
Persist assist pharmaceutical companies in developing long-acting formulations 50% faster. Because the formulation development process is manual and relies on scientific intuition, it takes a pharmaceutical company 5-10 years to develop a long acting formulation for a drug. This effort is divided into five years of pre-clinical development and five years of clinical testing. Their goal is to use machine learning and automation to reduce the time required for pre-clinical formulation development to three months, making the formulation development process 50% faster.
Company Facts
- Founded: 2022
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $16.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2025)
- Website: https://www.persist-ai.com
- Phone: 1 510-921-0563
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/persist-ai-64769 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.